Verastem Earnings
NASDAQ: VSTMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
8.38+0.27 (+3.33%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.44
Verastem earnings summary
Verastem is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $-0.44.
Summary generated from market data by MetaCap's automated system. Methodology